SEC Form 4 · accession 0001209191-16-114107
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Macaluso
Director
Period of report
Apr 11, 2016
Accepted (ET)
Apr 13, 2016 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option Grant | $0.56 | Apr 11, 2016 | A | 100,000 | A | Apr 11, 2016 | Apr 10, 2026 | Common Stock | 100,000 | 100,000 | D |
| Employee Stock Option Grant | $1.51 | holding | — | — | — | Nov 11, 2015 | Nov 11, 2025 | Common Stock | 125,000 | 125,000 | D |